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REVIEW
Abstract: Various diagnostic imaging modalities have been used for quantitative left ventricular 
(LV) parameters. Because of the suboptimal value of the most widely used technology, two-
dimensional (2D) echocardiography, 3D ultrasonographic imaging has improved accuracy for 
LV volume and function. Single photon emission computed tomography (SPECT) is another 
diagnostic method where LV volumetric and functional parameters can be accurately provided 
by gated myocardial perfusion tomographic slices. First pass radionuclide venticulography is 
another imaging modality which has some practical limitations. Despite lower ejection fraction 
(EF) values compared with invasive approach, noninvasive techniques are accurate in deter-
mination of normal and depressed EF. Noninvasive techniques with 3D approach including 
gated SPECT are beneﬁ  cial for not only global but also regional LV evaluation. It has been 
mentioned that the slight difference between echocardiography and SPECT could be caused 
by the diverse population studied. The results of diagnostic stress tests support that SPECT is 
feasible to use in evaluation of LV volume and functional analysis. Magnetic resonance imaging 
is an expensive modality to use routinely, but it preserves its importance in selected patients 
for providing precise LV geometric data.
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Introduction
Various diagnostic imaging modalities have been used for calculation of left ven-
tricular (LV) volume. Two-dimensional (2D) echocardiography is most widely used 
technology, but it is suboptimal for detection of LV volume due to the complex LV 
cavity geometry. In ultrasonographic assessment of LV volumes, current 2D echo-
cardiographic methods to quantitate ventricular performance require image acquisi-
tion from standardized scanning planes. LV volume is calculated from assumptions 
that the ventricular cavity can be represented by individual geometric ﬁ  gures or their 
combination. Both limitations of acoustic access and distortion of ventricular shape 
may invalidate these assumptions of standardized imaging planes and geometry, and 
lead to errors in calculating ventricular volume (Teichholz et al 1976).
Regional diversity of LV may be a difﬁ  culty of echocardiographic volume assess-
ment in clinical practice. It has been shown that simpliﬁ  ed echocardiographic recon-
struction used in conjunction with tissue harmonic imaging and automated endocardial 
border extraction accurately calculates LV volume and function in patients with regional 
wall motion abnormalities or distorted LVs caused by ischemic heart disease (Mele 
et al 2004). 3D ultrasonographic imaging provides improved accuracy for LV volume 
and function compared with current 2D algorithms (Siu et al 1995; Nosir et al 1996). In 
3D reconstruction, the technique required many cardiac cycles to reconstruct the heart, 
with considerable artifact due to respiratory and patient movement (Salustri et al 1996). 
Single photon emission computed tomography: 
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An integrated system may provide better agreement between 
LV volumes calculated by 3D reconstruction and actual vol-
umes (Handschumacher et al 1993).
Increased LV volumes are associated with high mortal-
ity, adverse cardiovascular events, and worse prognosis (Siu 
et al 1995). Although LV volumes have important prognostic 
implications, its evaluation is commonly underestimated in 
practice. If it is evaluated accurately, it provides additional 
incremental value to risk assessment and guides further 
therapy. Real-time 3D echocardiography has been compared 
with TI-201 single photon emission computed tomography 
(SPECT), cardiac magnetic resonance imaging (MRI) and 
found to be accurate and reproducible for the measurement 
of LV volumes for risk assessment in ischemic heart disease 
and dilated cardiomyopathy (Chan et al 2006).
Determination of regional LV diversity is the main 
difﬁ  culty not only for ischemic heart disease and volume 
overload, but for hypertrophied hearts. The novel modality by 
application of real-time 3D imaging technology can improve 
understanding of the spatial relations of various cardiac struc-
tures and offers the potential for more accurate volumetric 
quantization (Gopal et al 1992). We previously have used 
real-time 3D imaging to evaluate total and segmental LV 
volume in patients with LV hypertrophy and have described 
the details in regional geometry and global LV morphology 
(Yalçin et al 2000). Using 3D volumetric data, it has become 
possible to evaluate regional and global LV geometries espe-
cially in patients with LV geometric distortion or complex 
LV morphology. However, 3D approach is not a widely used 
echocardiographic method in clinical practice.
SPECT is one of the diagnostic modalities to evaluate LV 
volumetric and functional parameters accurately provided 
by gated myocardial perfusion tomographic slices. Gated 
perfusion tomographic slices have been used for volume 
calculations which includes 2D geometric assumptions 
and 3D approaches. Geometric modeling has been used for 
manually 2D calculation of ejection fraction (EF) using gated 
myocardial perfusion SPECT which has provided acceptable 
correlation with equilibrium multigated blood-pool and with 
contrast ventriculography (DePuey et al 1993; Mochizuki 
et al 1997). In healthy young subjects, post-exercise cardiac 
changes affect systolic functions detected on gated thallium 
myocardial perfusion scintigraphy, resulting in a smaller 
heart size during stress. However, the absence of these 
ﬁ  ndings in the elderly suggests a decrease in contractility 
with age (Aktas ¸ et al 2005). In addition to aging, decreased 
contractility may be detected by gated myocardial perfu-
sion SPECT in postischemic stunning due to stress-induced 
ischemic episode (Johnson et al 1997). Therefore, Johnson 
and colleagues (1997) suggested that the presence of post-
ischemic reduction in the post-stress EF may be another 
marker of disease severity and reduced event-free survival.
It was also reported that gated myocardial perfusion 
SPECT with Tc-99m labeled radiopharmaceutical may pro-
vide more objective imaging data than Tl-201 because gated 
SPECT performed with Tc-99m labeled radiopharmaceutical 
gives better image quality than Tl-201 due to higher myo-
cardial count rate. So when objective myocardial function 
monitoring is needed Tc-99m labeled radiopharmaceutical 
could be a reasonable method (Hyun et al 2001).
The number of gated frames per cardiac cycle in myo-
cardial gated SPECT may inﬂ  uence the accuracy of both EF 
and wall thickening. It has been shown that an 8-frame study 
results in a mismall constant and predictable decrease of 
0.04 in EF compared with a 16-frame study (Germano et al 
1995). First pass radionuclide venticulography is another 
imaging modality for EF calculations in which 32 frames per 
cardiac cycle are used. Despite high frame numbers, ﬁ  rst pass 
radionuclide venticulography has some practical limitations 
like giving functional data only at the time of injection 
(Yoshioka et al 1999). Gated myocardial perfusion SPECT 
has been used with automated technology and has given a 
satisfactory result (Nichols et al 1997). It has been shown 
that automated edge-detection algorithm is well correlated 
with contrast left ventriculogram and MRI (Mochizuki et al 
1997; Yoshioka et al 1999).
Planar multigated acquisition is one of the most common 
used technologies for EF and volume calculation. However, 
it is difﬁ  cult to calculate EF of the ventricules due to atrial 
overlap so SPECT studies are widely used (Lu et al 1994). 
On the other hand, SPECT studies are not successful in right 
ventricular EF calculation which is feasibly evaluated by ﬁ  rst 
pass radionuclide ventriculography (Massardo et al 2007). 
Also in multigated SPECT ventriculography, we could not 
obtain an idea of the perfusion of the myocardium even if 
we can begin imaging a few hours later, which differs from 
ﬁ  rst pass radionuclide ventriculography in which imaging 
must began as soon as possible after injection (Borges-Neto 
1997). In the literature, it is stated that gated myocardial 
perfusion SPECT which gives perfusion in addition to EF 
and wall motion analysis is superior to gated blood pool 
SPECT (Meine et al 2004).
Especially in coronary artery disease (CAD) patients, 
gated myocardial perfusion SPECT gives us more 
information than other technologies used for EF and volume 
calculations. With the quantitative gated SPECT (QGS) Vascular Health and Risk Management 2008:4(5) 1071
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method, even in normal perfusion, we can detect wall 
motion abnormalities which will inﬂ  uence the survival of 
CAD patients (Stegger et al 2007). It has been documented 
that despite small systematic differences, agreement 
between gated myocardial SPECT and MRI is good over 
a wide range of volumes and EF values using the QGS 
method (Schaefer et al 2005).
The variables provided by exercise radionuclide 
angiocardiography predicts cardiac death in patients with 
CAD (Jones et al 1991). However, noninvasive assessment 
of EF usually has been found to be lower than that detected 
by angiography (Nichols et al 1998; Vourvouri et al 2001; 
Habash-Bseiso et al 2005). Despite lower EF values by 
noninvasive assessment, noninvasive techniques are accurate 
in determination of normal and depressed EF (Habash-Bseiso 
et al 2005). The quantiﬁ  cation of inﬂ  uence of ﬁ  ltering and 
pixel size parameters on measured LV volumes for gated 
blood pool SPECT may be beneficial in correction of 
overestimation (Debrun et al 2005). SPECT has shown a 
slightly lower EF than that measured by echocardiography 
(Vourvouri et al 2001; Habash-Bseiso et al 2005), this could 
be also caused by diverse population studied (Albrechtsson 
et al 1982).
SPECT with boundary detection method also has shown 
a good correlation with equilibrium multigated blood-pool 
and MRI volumes (Faber et al 1988, 1991). Detection of 
boundaries for volume calculations may be possible in 
patients who have defect extending more than 25% of the 
myocardium (Nichols et al 1997). Border detection becomes 
more complicated in apical defects, it has been forced the 
wall to be a smooth connection between noninfarcted por-
tions of the wall (Faber et al 1999). Finally, positron emission 
tomography from nuclear studies has been used accurately 
for global and regional detection of LV function (Kanayama 
et al 2007). It has given an acceptable result for LV volumes 
and EF in comparison with MRI and angiography (Schae-
fer et al 2003). Among the noninvasive modalities, MRI 
is considered the gold standard, because of high accuracy 
and reproducibility for volume measurements (Barkhausen 
et al 2001). It has been used for assessment of myocardial 
thickness and regional myocardial function quantitatively 
(Pﬂ  ugfelder et al 1988).
In conclusion, gated myocardial perfusion SPECT is 
feasible for evaluation of LV volume and functional analysis 
in routine clinical practice. MRI preserves its importance in 
selected patients to determine more precise LV geometric 
data in patients with cardiac diseases, but it is unfortunately 
more expensive to use routinely.
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